Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R&D

This article was originally published in RAJ Devices

Executive Summary

European Parliament votes to raise research funding

European Parliament votes to raise research funding

The European Parliament has voted to adopt the European Commission's report on the Seventh Framework Programme (FP7) for research and development from 2007 to 2013. While the commission's original proposal of €72 billion was rejected, the programme's budget was increased to €50 billion from the previous framework programme's budget of €16 billion.

The commission's report proposed activities centred around nine thematic areas of research, including health; food, agriculture and biotechnology; and nanosciences, nanotechnologies, materials and new production technologies1. Parliament named health as a particular priority2.

Part of FP7 involved funding for stem cell research, which ran into opposition from representatives of countries such as Germany, Italy, Poland and Austria. These countries wanted to deny funding for stem cell research across the EU, even in countries where the research is legal, but the funding was approved.

Opponents of stem cell research also proposed that FP7 should only finance research on stem cell lines created before 31 December 2003, but this was also narrowly defeated. However, Parliament ruled that FP7 may not finance research into human cloning for reproductive purposes, or in which human embryos are created solely for research purposes or the harvesting of stem cells.

Reference

1. The Regulatory Affairs Journal - Devices, 2005, 13(3), 166-167

2. European Parliament press release, 17 June 2006, www.europarl.europa.eu/news/public/story_page/057-9077-163-06-24-909-20060615STO09076-2006-12-06-2006/default_en.htm

(c) Informa UK Ltd 2006

Latest Headlines
See All
UsernamePublicRestriction

Register

SC094123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel